CL

Business profile & competitive position

Colgate-Palmolive Company sits in the Consumer Defensive sector, specifically the Household & Personal Products industry. Its operations are organized into two segments. The first is Oral, Personal and Home Care, which includes toothpaste, toothbrushes, soaps, deodorants, skin health products, cleaners and fabric conditioners. The second is Hill’s Pet Nutrition, focused on specialty dog and cat foods. The company markets these products in more than 200 countries and territories through retailers, wholesalers, eCommerce retailers, veterinarians and select direct-to-consumer channels. In 2025, Oral Care accounted for 44% of worldwide net sales, Personal Care for 17%, Home Care for 16% and Pet Nutrition for 23%.

The margin and risk profile are what one would expect from a global staples operator, though one figure demands caution. The 9.7% net margin is consistent with a large branded consumer-products business that has pricing power and scale. The reported return on equity of 631.1%, however, is mechanically extreme. ROE at that level is almost always the product of a very small equity base or substantial financial leverage rather than a pure read of competitive strength. Net margin is therefore the cleaner signal of operating health, while the 0.32 beta confirms the low-volatility, defensive character of the stock.

Financial posture

Colgate-Palmolive’s market capitalization stands at approximately $71.0 billion, and the stock trades at a trailing P/E of 34.9. That multiple is elevated for a consumer-staples name and suggests the market is assigning a premium to earnings stability. The 9.7% net margin underpins the profitability of the model, and the 0.32 beta indicates the stock has historically moved less than one-third as much as the broad market. For income-oriented holders, the valuation context is meaningful: a richer P/E mechanically compresses yield, which helps explain why recent commentary has grouped the name with other dividend plays in a low-yield environment.

The 631.1% ROE remains the outlier. Because the number is so far above any sustainably achievable economic return, it should be interpreted as a balance-sheet artifact rather than evidence of a dramatically widened moat. The real competitive position rests on global brand equity, repeat-purchase categories, shelf presence and a distribution network that reaches veterinarians for Hill’s and mass retailers for the core personal- and home-care lines.

Strategic priorities & outlook

According to its most recent 10-K filing, Colgate-Palmolive’s near-term priorities fall into four areas. First, it is focused on driving organic sales growth and delivering consistent, compounded earnings-per-share growth. Second, it aims to achieve operational efficiencies while growing free cash flow and using the balance sheet efficiently. Third, it plans to leverage global brand reach, science-based innovation, an agile supply chain and best-in-class omni-channel demand generation. Fourth, it is building capabilities in data, analytics and artificial intelligence alongside what it describes as a high-impact, inclusive culture.

The filing also surfaces two operational facts that matter for risk assessment. Walmart and its affiliates represented approximately 11% of 2025 net sales, the only customer relationship above the 10% threshold. As of December 31, 2025, the company employed approximately 33,600 people across more than 100 countries, with over 84% of that workforce located outside the United States. That geographic footprint supports the global top line but also creates exposure to international regulation, currency translation and cross-border logistics.

Macro & geopolitical exposure

As a Household & Personal Products company, Colgate-Palmolive is defensive but not isolated from macro and geopolitical forces. The most direct exposure is commodity costs. Raw materials such as surfactants, oils, packaging plastics, fragrances and other chemicals feed into soaps, cleaners, toothpaste and deodorants, while Hill’s Pet Nutrition depends on proteins, grains and specialty ingredients. Sustained commodity inflation or supply-chain disruption can pressure gross margins if pricing power is not sufficient to pass those costs through.

Currency is another material factor. With operations spanning more than 200 countries and the majority of employees located outside the United States, a meaningful portion of revenue and expenses is denominated in foreign currencies. A stronger U.S. dollar would reduce the translated value of overseas earnings, while a weaker dollar would have the opposite effect. Trade policy, including tariffs on inputs or finished goods, can affect both costs and cross-border competitiveness. The industry also faces regulation around product safety, labeling, environmental claims and, for Hill’s, pet-food standards. Inflation-driven consumer trade-down is a longer-term risk in staples, although essential categories such as oral care tend to hold up better than discretionary spending.

Recent developments

Recent headlines have reflected both the stock’s defensive income appeal and normal institutional position changes. On September 6, 2026, fool.com noted that the S&P 500’s dividend yield is at historic lows and included Colgate-Palmolive among dividend stocks to consider in September. On September 4, 2026, 247wallst.com listed the company as one of three “all-weather” dividend stocks that keep writing bigger checks. The same day, defenseworld.net reported that Baypointe Partners LLC had sold shares of Colgate-Palmolive, a routine portfolio update rather than a company-specific event. On September 3, 2026, zacks.com published “Here’s Why Colgate-Palmolive (CL) is a Strong Growth Stock,” emphasizing earnings momentum.

The price snapshot accompanying these headlines has the stock at $88.77, below its 50-day exponential moving average of $91.00, with an RSI of 40.2. That reading is near the lower end of neutral short-term momentum.

Earnings behavior & post-earnings drift

Colgate-Palmolive has an unblemished earnings record over the last eight reported quarters, beating estimates in all eight, with an average earnings surprise of 3.3%. The average five-day price move after earnings across those quarters is 2.32% to the upside, classifying the post-earnings drift as “up.”

The most recent four quarters illustrate a consistent pattern. On July 31, 2026, the company reported EPS of $0.99 against an estimate of $0.947, a 4.5% beat; the stock fell 1.56% the next day but rose 2.16% over the following five trading days. On May 1, 2026, EPS came in at $0.97 versus $0.943, a 2.9% beat; the next-day drop was 2.17%, while the five-day drift was a modest 0.33%. On January 30, 2026, EPS was $0.95 against $0.912, a 4.2% beat; the stock rose 1.77% the next day and 4.56% over the next five sessions. On October 31, 2025, EPS of $0.91 beat the $0.889 estimate by 2.4%; the stock dropped 2.69% the next day but recovered 2.22% over the subsequent five days.

The historical pattern is one of reliable beats but inconsistent immediate reactions. In three of the last four reports, the stock sold off the next day even though the five-day drift remained positive on average. The next scheduled report is October 30, 2026, before the market opens, with a current consensus EPS estimate of $0.92.

For a deeper dive into how sell-side and institutional models are currently weighing Colgate-Palmolive’s valuation, margin trajectory and upcoming October 30, 2026 earnings report, consult the full institutional verdict on the platform.